PET/CT imaging in systemic lupus erythematosus

Annals of the New York Academy of Sciences

Volumn 1228, Issue 1, 2011, Pages 71-80

  Curiel, Rodolfo ^a   Akin, Esma A ^a   Beaulieu, Gregory ^a   Depalma, Louis ^a   Hashefi, Mandana ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CNS; FDG; Inflammation; Lymphadenopathy; PET; SLE

Indexed keywords

CD40 LIGAND; CELL ADHESION MOLECULE; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; GLUCOSE; GLUCOSE TRANSPORTER 1; HEXOKINASE; MESSENGER RNA;

ALOPECIA; ALZHEIMER DISEASE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN INJURY; CELL INFILTRATION; CELL MEMBRANE PERMEABILITY; CELL METABOLISM; CHEMOTAXIS; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COMPLEMENT SYSTEM; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; FATIGUE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEPATOMEGALY; HUMAN; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY DISEASE; KIKUCHI DISEASE; LEUKOCYTE; LYMPH NODE; LYMPHADENOPATHY; LYMPHOCYTE ACTIVATION; LYMPHOID ORGAN; LYMPHOMA; MACROPHAGE; MORBIDITY; MORTALITY; MOTOR DYSFUNCTION; MOUTH ULCER; NEUROIMAGING; NEUROPSYCHIATRY; NEUTROPHIL; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PERIPHERAL LYMPHOCYTE; PHAGOCYTOSIS; PROGNOSIS; RETICULOENDOTHELIAL SYSTEM; SENSITIVITY AND SPECIFICITY; SKIN ULCER; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TISSUE INJURY; VASODILATATION; WEIGHT REDUCTION; WHITE MATTER;

EID: 79959772965     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06076.x     Document Type: Article

References (43)

1. Cancro, M.P., D.P. D'Cruz & A. Khamashta 2009. The role of B lymphocyte stimulator (Blys) in systemic lupus erythematosus. J. Clin. Invest. 119: 1066-1073.
2. Raghavan, M. & P.J. Bjorkman 1996. Fc receptors and their interactions with immunoglobulins. Ann. Rev. Cell Dev. Biol. 12: 181-220.
3. Truedsson, L., A.A. Bengtsson & G. Sturfelt 2007. Complement deficiencies and systemic lupus erythematosus. Autoimmunity 40: 560-566.
4. 18F-fluorodeoxyglucose positron emission tomography in patients with connective tissue disease. Jpn. J. Radiol. 28: 405-413.
5. Rennen, H., O. Boerman & J.G. Oyen, et al 2001. Imaging infection inflammation in the new millennium. Eur. J. Nucl. Med. 28: 241-252.
6. Gotthardt, M., C.P. Bleeker-Rovers, O.C. Boerman, et al 2010. Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J. Nucl. Med. 51: 1937-1949.
7. 18F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography(computed tomography (PET(CT): accumulated data from four years of experience. Semin. Nucl. Med. 37: 202-222.
8. Hamilton, J.A. & P. Tak 2009. The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum. 60: 1210-1221.
9. Basu, S., R. Kumar & A. Alavi 2010. PET and PET-CT imaging in infection and inflammation: its critical role in assessing complications related to therapeutic interventions in patients with cancer. Indian J. Cancer 47: 371-379.
10. Gamelli, R.L., H. Liu, L. He, et al 1996. Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice. J. Leukoc. Biol. 59: 639-647.
11. Yamada, A., K. Oguchi & M. Fukushima, et al 2006. Evaluation of 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression. Ann. Nucl. Med. 20: 597-604.
12. Schuster, D.P., S.L. Brody, Z. Zhou, et al 2006. Regulation of lipopolysaccharide-induced increases in neutrophil glucose uptake. Am. J. Physiol. Lung Cell Mol. Physiol. 292: 845-851.
13. 18F-FDG PET and PET(CT in fever of unknown origin. J. Nucl. Med. 48: 35-45.
14. Govoni, M., G. Castellino, M. Padovan, et al 2004. Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus. Lupus 13: 149-158.
15. Gatto, D. & R. Brink 2010. The germinal center reaction. J. Allergy Clin. Immunol. 126: 898-907.
16. Shapira, Y. & A.W. Weinberger 1996. Lymphadenopathy in systemic lupus erythematosus. Prevalence and relation to disease manifestations. Clin. Rheumatol. 15: 335-338.
17. Nowak, M., J. Carrasquillo, C. Yarboro, et al 2004. A pilot study of the use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emmission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus. Arthritis Rheum. 50: 1233-1238.
18. Torabi, M., S. Aquino & G. Harisinghani 2004. Current concepts in lymph node imaging. J. Nucl. Med. 45: 1509-1518.
19. Melikoglu, M. & M. Melikoglu 2008. The clinical importance of lymphadenopathy in systemic lupus erythematosus. Acta Reumatol. Port. 33: 402-406.
20. Neto, N., K. Bonfiglioli, F. Milanez, et al 2010. Lymphadenopathy and systemic lupus erythematosus. Bras. J. Rheumatol. 50: 96-101.
21. Kojima, M., S. Nakamura, Y. Morishita, et al 2000. Reactive follicular hyperlasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistological study of 21 cases. Pathol. Int. 50: 304-312.
22. Khanna, D., A. Shrivastava, P. Malur, et al 2010. Necrotizing lymphadenitis in systemic lupus erythematosus. J. Clin. Rheumatol. 16: 123-124.
23. King, J. & K. Costenbader 2007. Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL). Clin. Rheumatol. 26: 1491-1494.
24. Zhuang, B., D.A. Torigian, et al 2009. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl. Med. 39: 124-145.
25. Meller, J., C.O. Sahlmann, O. Gurocak, et al 2009. FDG-PET in patients with fever of unknown origin: the importance of diagnosing large vessel vasculitis. Q. J. Nucl. Med. Mil. Imaging 53: 51-63.
26. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. 1999. The American College of Rheumatology nomenclature and case definition for neuropsychiatric lupus syndromes. Arthritis Rheum. 42: 599-608.
27. Sailer, M., W. Burchert, C. Ehrenheim, et al 1997. Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus. J. Neurol. 244: 186-193.
28. Jong, B.M., J. Pruim, L.G.F. Sinnige, et al. 1999. Regional specific changes of cerebral metabolism in systemic lupus erythematosus identified by positron emission tomography. Eur. Neurol. 41: 187-193.
29. Ishimori, M.L., B.D. Pressman, D.J. Wallace, et al 2007. Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE? 16: 436-443.
30. Fong, K.Y. & J. Thumboo 2010. Neuropsychiatric lupus: clinical challenges, brain-reactive autoantibodies and treatment strategies. 19: 1399-1403.
31. Okamoto, H., A. Kobayashi & H. Yamanaka 2010. Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus. J. Biomed. Biotechnol. 2010: 1-8.
32. Brooks, W.M., W.L. Sibbitt, M. Kornfeld, et al 2010. The histologic associates of neurometabolite in fatal neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 62: 2055-2063.
33. Kao, C.H., Y.J. Ho, J.L. Lan, et al 1999. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings. 42: 61-68.
34. Kao, C.H., J.L. Lan, S.P. Changlai, et al 1999. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus. Eur. J. Nucl. Med. 26: 129-134.
35. Baizabal-Carvallo, J.F., M. Alonso-Juarez & M. Koslowski 2011. Chorea in systemic lupus erythematosus. J. Clin. Rheumatol. 17: 69-72.
36. Carecchio, M., C. Comi & C. Varrasi, et al 2009. Complex movement disorder in primary antiphospholipid syndrome: a case report. J. Neurol. Sci. 15: 1-2.
37. Krakawer, M. & I. Law 2009. FDG PET brain imaging in neuropsychiatric systemic lupus erythematosus with choreic symptoms. Clin. Nucl. Med. 34: 122-123.
38. Stoppe, G., K. Wildhagen, J.W. Seidel, et al 1990. Positron emission tomography in neuropsychiatric lupus erythematosus. Neurology 40: 304-308.
39. Weiner, S.M., A. Otte, M. Schumacher, R. Klein, et al 2000. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann. Rheum. Dis. 59: 377-385.
40. Weiner, S.M., A. Otte, M. Schumacher, I. Brink, et al 2000. Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus. Lupus 9: 386-389.
41. Otte, A., T.M. Ettlin, E.U. Nitzche, K. Wachter & S. Hoegerle 1997. PET and SPECT in whiplash syndrome: a new approach to a forgotten brain? J. Neurol. Neurosurg. Psychiatry 63: 368-372.
42. Mega, M.S., T. Chu, J.C. Mazziotta, et al 1999. Mapping biochemistry to metabolism: FDG-PET and amyloid burden in Alzheimer's disease. NeuroReport 10: 2911-2917.
43. Mochizuki, T., E. Tsukamoto, Y. Kuge, et al 2001. FDG-uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J. Nucl. Med. 42: 1551-1555.